Moviprep Orange (Ascorbic Acid, Sodium Ascorbate, Potassium Chloride, Sodium Chloride, Sodium Sulfate Anhydrous, Macr)

Moviprep Orange, an osmotic laxative, is used for bowel cleansing in preparation for gastrointestinal endoscopic procedures.

• Colonoscopy: provides thorough colon cleansing to enable clear visualization of the mucosa.
• Sigmoidoscopy: clears the distal colon and rectum for optimal examination.
• Pre‑operative colorectal surgery: evacuates the bowel to reduce contamination risk during surgery.

• The formulation contains ascorbic acid, sodium ascorbate, potassium chloride, sodium chloride and sodium sulfate, which remain largely non‑absorbed in the intestine. These solutes create an osmotic gradient that draws water into the lumen, increasing intraluminal volume and stimulating rapid peristalsis, leading to swift evacuation of colonic contents. The increased fluid volume softens stool and promotes transit, while the electrolyte composition helps maintain ionic balance during the cleansing process.

Moviprep Orange may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects

• Nausea: mild queasy feeling that may resolve after the dose.
• Abdominal cramping: intermittent stomach pain associated with bowel movements.
• Bloating: sensation of fullness due to gas accumulation.
• Vomiting: occasional expulsion of stomach contents, usually self‑limiting.

Serious or Rare Side Effects

• Electrolyte imbalance: significant changes in sodium, potassium or chloride levels that may require medical attention.
• Severe dehydration: excessive fluid loss leading to dizziness, low blood pressure or fainting.
• Renal impairment: reduced kidney function triggered by fluid and electrolyte shifts.
• Allergic reaction: rash, itching, swelling or rare anaphylaxis requiring immediate care.

Before using Moviprep Orange, certain precautions should be observed to ensure safety and effectiveness.

• Renal function assessment: evaluate kidney function in patients with known renal disease before administration.
• Electrolyte monitoring: check serum sodium, potassium and chloride levels prior to use.
• Dehydration risk: avoid in patients with severe dehydration or ongoing fluid loss.
• Concomitant medications: review diuretics, ACE inhibitors or potassium‑sparing agents that may affect electrolyte balance.
• Bowel obstruction contraindication: do not use in patients with known or suspected intestinal blockage.
• Store at ambient temperature: keep the solution in its original container, protect from moisture and direct sunlight.

Moviprep Orange can interact with other medicines, altering its efficacy or increasing the risk of adverse events.

Major Interactions (Avoid)

• Loop diuretics: may cause significant electrolyte depletion when combined.
• ACE inhibitors or ARBs: increased risk of hyperkalemia.
• Potassium‑sparing diuretics: additive potassium load.
• Antacids containing magnesium: may reduce the osmotic effect.

Moderate Interactions (Monitor Closely)

• NSAIDs: can affect renal function, requiring monitoring.
• Oral rehydration solutions: may dilute the osmotic gradient, reducing efficacy.
• Antidiarrheal agents (e.g., loperamide): may counteract the intended laxative effect.